Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Related structures:
AlphaFold database: E9AIR1
Term | Name | Level | Count |
---|---|---|---|
GO:0001510 | RNA methylation | 4 | 2 |
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 2 |
GO:0006396 | RNA processing | 6 | 2 |
GO:0006399 | tRNA metabolic process | 7 | 2 |
GO:0006400 | tRNA modification | 6 | 2 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 2 |
GO:0006807 | nitrogen compound metabolic process | 2 | 2 |
GO:0008033 | tRNA processing | 8 | 2 |
GO:0008152 | metabolic process | 1 | 2 |
GO:0009451 | RNA modification | 5 | 2 |
GO:0009987 | cellular process | 1 | 2 |
GO:0016070 | RNA metabolic process | 5 | 2 |
GO:0030488 | tRNA methylation | 5 | 2 |
GO:0032259 | methylation | 2 | 2 |
GO:0034470 | ncRNA processing | 7 | 2 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 2 |
GO:0034660 | ncRNA metabolic process | 6 | 2 |
GO:0043170 | macromolecule metabolic process | 3 | 2 |
GO:0043412 | macromolecule modification | 4 | 2 |
GO:0043414 | macromolecule methylation | 3 | 2 |
GO:0044237 | cellular metabolic process | 2 | 2 |
GO:0044238 | primary metabolic process | 2 | 2 |
GO:0044260 | obsolete cellular macromolecule metabolic process | 3 | 2 |
GO:0046483 | heterocycle metabolic process | 3 | 2 |
GO:0071704 | organic substance metabolic process | 2 | 2 |
GO:0090304 | nucleic acid metabolic process | 4 | 2 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 2 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 12 |
GO:0005488 | binding | 1 | 12 |
GO:0008168 | methyltransferase activity | 4 | 12 |
GO:0008171 | O-methyltransferase activity | 5 | 12 |
GO:0008173 | RNA methyltransferase activity | 4 | 12 |
GO:0008175 | tRNA methyltransferase activity | 5 | 12 |
GO:0016740 | transferase activity | 2 | 12 |
GO:0016741 | transferase activity, transferring one-carbon groups | 3 | 12 |
GO:0043167 | ion binding | 2 | 12 |
GO:0043169 | cation binding | 3 | 12 |
GO:0046872 | metal ion binding | 4 | 12 |
GO:0062105 | RNA 2'-O-methyltransferase activity | 5 | 12 |
GO:0106050 | tRNA 2'-O-methyltransferase activity | 6 | 12 |
GO:0140098 | catalytic activity, acting on RNA | 3 | 12 |
GO:0140101 | catalytic activity, acting on a tRNA | 4 | 12 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 2 | 12 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 89 | 93 | PF00656 | 0.452 |
CLV_NRD_NRD_1 | 224 | 226 | PF00675 | 0.505 |
CLV_NRD_NRD_1 | 294 | 296 | PF00675 | 0.679 |
CLV_NRD_NRD_1 | 363 | 365 | PF00675 | 0.523 |
CLV_NRD_NRD_1 | 366 | 368 | PF00675 | 0.474 |
CLV_PCSK_FUR_1 | 292 | 296 | PF00082 | 0.657 |
CLV_PCSK_FUR_1 | 364 | 368 | PF00082 | 0.340 |
CLV_PCSK_KEX2_1 | 224 | 226 | PF00082 | 0.505 |
CLV_PCSK_KEX2_1 | 294 | 296 | PF00082 | 0.679 |
CLV_PCSK_KEX2_1 | 363 | 365 | PF00082 | 0.566 |
CLV_PCSK_KEX2_1 | 366 | 368 | PF00082 | 0.517 |
CLV_PCSK_PC7_1 | 359 | 365 | PF00082 | 0.625 |
CLV_PCSK_SKI1_1 | 128 | 132 | PF00082 | 0.355 |
CLV_PCSK_SKI1_1 | 194 | 198 | PF00082 | 0.487 |
CLV_PCSK_SKI1_1 | 224 | 228 | PF00082 | 0.566 |
CLV_PCSK_SKI1_1 | 359 | 363 | PF00082 | 0.604 |
CLV_PCSK_SKI1_1 | 390 | 394 | PF00082 | 0.484 |
CLV_Separin_Metazoa | 284 | 288 | PF03568 | 0.589 |
CLV_Separin_Metazoa | 405 | 409 | PF03568 | 0.600 |
DEG_Nend_UBRbox_1 | 1 | 4 | PF02207 | 0.474 |
DEG_SCF_FBW7_1 | 431 | 437 | PF00400 | 0.451 |
DEG_SPOP_SBC_1 | 12 | 16 | PF00917 | 0.407 |
DEG_SPOP_SBC_1 | 78 | 82 | PF00917 | 0.673 |
DOC_CKS1_1 | 431 | 436 | PF01111 | 0.460 |
DOC_MAPK_gen_1 | 189 | 198 | PF00069 | 0.345 |
DOC_PP1_RVXF_1 | 374 | 381 | PF00149 | 0.612 |
DOC_PP2B_LxvP_1 | 210 | 213 | PF13499 | 0.504 |
DOC_PP2B_PxIxI_1 | 416 | 422 | PF00149 | 0.491 |
DOC_PP4_FxxP_1 | 172 | 175 | PF00568 | 0.505 |
DOC_USP7_MATH_1 | 108 | 112 | PF00917 | 0.662 |
DOC_USP7_MATH_1 | 242 | 246 | PF00917 | 0.539 |
DOC_USP7_MATH_1 | 265 | 269 | PF00917 | 0.579 |
DOC_USP7_MATH_1 | 340 | 344 | PF00917 | 0.471 |
DOC_WW_Pin1_4 | 13 | 18 | PF00397 | 0.431 |
DOC_WW_Pin1_4 | 156 | 161 | PF00397 | 0.505 |
DOC_WW_Pin1_4 | 235 | 240 | PF00397 | 0.459 |
DOC_WW_Pin1_4 | 430 | 435 | PF00397 | 0.674 |
DOC_WW_Pin1_4 | 55 | 60 | PF00397 | 0.419 |
LIG_14-3-3_CanoR_1 | 144 | 154 | PF00244 | 0.585 |
LIG_14-3-3_CanoR_1 | 203 | 213 | PF00244 | 0.607 |
LIG_14-3-3_CanoR_1 | 267 | 276 | PF00244 | 0.366 |
LIG_14-3-3_CanoR_1 | 367 | 373 | PF00244 | 0.499 |
LIG_14-3-3_CanoR_1 | 379 | 385 | PF00244 | 0.528 |
LIG_Actin_WH2_2 | 273 | 289 | PF00022 | 0.599 |
LIG_BIR_III_2 | 382 | 386 | PF00653 | 0.588 |
LIG_BIR_III_4 | 113 | 117 | PF00653 | 0.435 |
LIG_BIR_III_4 | 312 | 316 | PF00653 | 0.266 |
LIG_BRCT_BRCA1_1 | 301 | 305 | PF00533 | 0.511 |
LIG_BRCT_BRCA1_1 | 46 | 50 | PF00533 | 0.445 |
LIG_BRCT_BRCA1_1 | 79 | 83 | PF00533 | 0.484 |
LIG_Clathr_ClatBox_1 | 165 | 169 | PF01394 | 0.384 |
LIG_CSL_BTD_1 | 431 | 434 | PF09270 | 0.452 |
LIG_deltaCOP1_diTrp_1 | 96 | 101 | PF00928 | 0.327 |
LIG_FHA_1 | 183 | 189 | PF00498 | 0.572 |
LIG_FHA_1 | 191 | 197 | PF00498 | 0.565 |
LIG_FHA_1 | 24 | 30 | PF00498 | 0.486 |
LIG_FHA_1 | 259 | 265 | PF00498 | 0.481 |
LIG_FHA_1 | 268 | 274 | PF00498 | 0.485 |
LIG_FHA_1 | 389 | 395 | PF00498 | 0.570 |
LIG_FHA_2 | 129 | 135 | PF00498 | 0.616 |
LIG_FHA_2 | 232 | 238 | PF00498 | 0.457 |
LIG_LIR_Apic_2 | 169 | 175 | PF02991 | 0.507 |
LIG_LIR_Gen_1 | 252 | 260 | PF02991 | 0.475 |
LIG_LIR_Gen_1 | 95 | 105 | PF02991 | 0.328 |
LIG_LIR_Nem_3 | 252 | 256 | PF02991 | 0.510 |
LIG_LIR_Nem_3 | 258 | 263 | PF02991 | 0.516 |
LIG_LIR_Nem_3 | 374 | 378 | PF02991 | 0.427 |
LIG_LIR_Nem_3 | 95 | 101 | PF02991 | 0.329 |
LIG_SH2_CRK | 41 | 45 | PF00017 | 0.496 |
LIG_SH2_STAP1 | 192 | 196 | PF00017 | 0.467 |
LIG_SH2_STAP1 | 260 | 264 | PF00017 | 0.435 |
LIG_SH2_STAT5 | 192 | 195 | PF00017 | 0.445 |
LIG_SH2_STAT5 | 215 | 218 | PF00017 | 0.448 |
LIG_SH2_STAT5 | 260 | 263 | PF00017 | 0.435 |
LIG_SH3_2 | 385 | 390 | PF14604 | 0.600 |
LIG_SH3_3 | 158 | 164 | PF00018 | 0.638 |
LIG_SH3_3 | 178 | 184 | PF00018 | 0.422 |
LIG_SH3_3 | 26 | 32 | PF00018 | 0.482 |
LIG_SH3_3 | 331 | 337 | PF00018 | 0.435 |
LIG_SH3_3 | 382 | 388 | PF00018 | 0.591 |
LIG_SH3_3 | 418 | 424 | PF00018 | 0.442 |
LIG_SH3_3 | 428 | 434 | PF00018 | 0.612 |
LIG_SUMO_SIM_par_1 | 255 | 262 | PF11976 | 0.459 |
LIG_TRFH_1 | 420 | 424 | PF08558 | 0.276 |
LIG_UBA3_1 | 123 | 128 | PF00899 | 0.362 |
LIG_WRC_WIRS_1 | 109 | 114 | PF05994 | 0.553 |
LIG_WRC_WIRS_1 | 260 | 265 | PF05994 | 0.556 |
LIG_WRC_WIRS_1 | 372 | 377 | PF05994 | 0.327 |
MOD_CK1_1 | 15 | 21 | PF00069 | 0.460 |
MOD_CK1_1 | 156 | 162 | PF00069 | 0.430 |
MOD_CK1_1 | 23 | 29 | PF00069 | 0.473 |
MOD_CK1_1 | 235 | 241 | PF00069 | 0.528 |
MOD_CK1_1 | 82 | 88 | PF00069 | 0.743 |
MOD_CK2_1 | 128 | 134 | PF00069 | 0.382 |
MOD_CK2_1 | 231 | 237 | PF00069 | 0.452 |
MOD_GlcNHglycan | 118 | 121 | PF01048 | 0.657 |
MOD_GlcNHglycan | 17 | 20 | PF01048 | 0.529 |
MOD_GlcNHglycan | 172 | 175 | PF01048 | 0.450 |
MOD_GlcNHglycan | 22 | 25 | PF01048 | 0.516 |
MOD_GlcNHglycan | 234 | 237 | PF01048 | 0.650 |
MOD_GlcNHglycan | 400 | 403 | PF01048 | 0.628 |
MOD_GlcNHglycan | 88 | 91 | PF01048 | 0.542 |
MOD_GlcNHglycan | 98 | 101 | PF01048 | 0.310 |
MOD_GSK3_1 | 11 | 18 | PF00069 | 0.413 |
MOD_GSK3_1 | 118 | 125 | PF00069 | 0.564 |
MOD_GSK3_1 | 204 | 211 | PF00069 | 0.549 |
MOD_GSK3_1 | 228 | 235 | PF00069 | 0.571 |
MOD_GSK3_1 | 351 | 358 | PF00069 | 0.639 |
MOD_GSK3_1 | 40 | 47 | PF00069 | 0.602 |
MOD_GSK3_1 | 430 | 437 | PF00069 | 0.509 |
MOD_GSK3_1 | 78 | 85 | PF00069 | 0.673 |
MOD_GSK3_1 | 92 | 99 | PF00069 | 0.420 |
MOD_NEK2_1 | 118 | 123 | PF00069 | 0.482 |
MOD_NEK2_1 | 154 | 159 | PF00069 | 0.722 |
MOD_NEK2_1 | 196 | 201 | PF00069 | 0.411 |
MOD_NEK2_1 | 259 | 264 | PF00069 | 0.546 |
MOD_NEK2_1 | 368 | 373 | PF00069 | 0.596 |
MOD_NEK2_1 | 398 | 403 | PF00069 | 0.509 |
MOD_NEK2_1 | 83 | 88 | PF00069 | 0.479 |
MOD_PIKK_1 | 118 | 124 | PF00454 | 0.478 |
MOD_PIKK_1 | 145 | 151 | PF00454 | 0.462 |
MOD_PIKK_1 | 64 | 70 | PF00454 | 0.574 |
MOD_PKA_2 | 190 | 196 | PF00069 | 0.333 |
MOD_PKA_2 | 202 | 208 | PF00069 | 0.406 |
MOD_PKA_2 | 286 | 292 | PF00069 | 0.605 |
MOD_PKA_2 | 378 | 384 | PF00069 | 0.550 |
MOD_PKB_1 | 357 | 365 | PF00069 | 0.599 |
MOD_Plk_4 | 259 | 265 | PF00069 | 0.448 |
MOD_Plk_4 | 329 | 335 | PF00069 | 0.429 |
MOD_Plk_4 | 40 | 46 | PF00069 | 0.575 |
MOD_ProDKin_1 | 13 | 19 | PF00069 | 0.436 |
MOD_ProDKin_1 | 156 | 162 | PF00069 | 0.504 |
MOD_ProDKin_1 | 235 | 241 | PF00069 | 0.460 |
MOD_ProDKin_1 | 430 | 436 | PF00069 | 0.677 |
MOD_ProDKin_1 | 55 | 61 | PF00069 | 0.432 |
TRG_DiLeu_BaEn_1 | 252 | 257 | PF01217 | 0.508 |
TRG_DiLeu_BaLyEn_6 | 174 | 179 | PF01217 | 0.470 |
TRG_DiLeu_LyEn_5 | 252 | 257 | PF01217 | 0.508 |
TRG_ENDOCYTIC_2 | 260 | 263 | PF00928 | 0.435 |
TRG_ENDOCYTIC_2 | 41 | 44 | PF00928 | 0.520 |
TRG_ER_diArg_1 | 188 | 191 | PF00400 | 0.343 |
TRG_ER_diArg_1 | 224 | 226 | PF00400 | 0.538 |
TRG_ER_diArg_1 | 292 | 295 | PF00400 | 0.649 |
TRG_ER_diArg_1 | 357 | 360 | PF00400 | 0.541 |
TRG_ER_diArg_1 | 363 | 366 | PF00400 | 0.539 |
TRG_Pf-PMV_PEXEL_1 | 136 | 141 | PF00026 | 0.450 |
TRG_Pf-PMV_PEXEL_1 | 225 | 229 | PF00026 | 0.461 |
TRG_Pf-PMV_PEXEL_1 | 408 | 413 | PF00026 | 0.544 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A1X0NJE0 | Trypanosomatidae | 31% | 90% |
A0A3Q8IG18 | Leishmania donovani | 56% | 95% |
A0A3S7WY71 | Leishmania donovani | 78% | 85% |
A4I0P4 | Leishmania infantum | 56% | 95% |
A4I0P5 | Leishmania infantum | 78% | 85% |
E9AWP4 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 58% | 95% |
E9AWP5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 79% | 86% |
Q4QAS6 | Leishmania major | 78% | 100% |
Q4QAS7 | Leishmania major | 56% | 100% |
V5BR90 | Trypanosoma cruzi | 32% | 82% |